Abstract

The renin-angiotensin-aldosterone system (RAAS) is implicated in hypertension and kidney disease. The developing kidney can be programmed by various early-life insults by so-called renal programming, resulting in hypertension and kidney disease in adulthood. This theory is known as developmental origins of health and disease (DOHaD). Conversely, early RAAS-based interventions could reverse program processes to prevent a disease from occurring by so-called reprogramming. In the current review, we mainly summarize (1) the current knowledge on the RAAS implicated in renal programming; (2) current evidence supporting the connections between the aberrant RAAS and other mechanisms behind renal programming, such as oxidative stress, nitric oxide deficiency, epigenetic regulation, and gut microbiota dysbiosis; and (3) an overview of how RAAS-based reprogramming interventions may prevent hypertension and kidney disease of developmental origins. To accelerate the transition of RAAS-based interventions for prevention of hypertension and kidney disease, an extended comprehension of the RAAS implicated in renal programming is needed, as well as a greater focus on further clinical translation.

Highlights

  • Hypertension and chronic kidney disease (CKD) are highly prevalent diseases around the world

  • We present a contemporary update of the renin–angiotensin-aldosterone system (RAAS), explaining its role on hypertension and kidney disease of developmental origins and emphasizing its links to other mechanisms

  • Another report showed that the protective effects of melatonin, a potent antioxidant, against programmed hypertension is attributed to increased renal ACE2 level [75]

Read more

Summary

Introduction

Hypertension and chronic kidney disease (CKD) are highly prevalent diseases around the world. Several potential molecular mechanisms involved in developmental programming of hypertension and kidney disease have been addressed, including aberrant RAAS, oxidative stress, nitric oxide (NO) deficiency, gut microbiota dysbiosis, dysregulated nutrient-sensing signals, epigenetic regulation, and reduced nephron number [6,7,8,9,13,14,18,19,20]. The classical RAAS is mainly made up of angiotensin-converting enzyme (ACE), angiotensin (ANG) II, and angiotensin II type 1 receptor (AT1R). We present a contemporary update of the RAAS, explaining its role on hypertension and kidney disease of developmental origins and emphasizing its links to other mechanisms. We highlight the potential reprogramming interventions that target the RAAS for prevention of developmental programming of hypertension and kidney disease.

The Programmed Kidney
Impact of RAAS in Renal Programming
Animal Models of Renal Programming
Classical RAAS Axis in Renal Programming
Non-Classical RAAS Axis in Renal Programming
Aldosterone in Renal Programming
Oxidative Stress
Nitric Oxide Deficiency
Reduced Nephron Number
Epigenetic Regulation
Others
Targeting on the RAAS as Reprogramming Strategies
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call